KatlamaC, DeeksSG, AutranB, Martinez-PicadoJ, van LunzenJ, RouziouxC, et al.: Barriers to a cure for HIV:New ways to target and eradicate HIV-1 reservoirs. Lancet, 2013; 381:2109–2117.
2.
SamerS, ArifMS, GironLB, ZukurovJPL, HunterJ, SantilloBT, et al.Sirtuin1 Inhibitor Nicotinamide Activates Latent HIV Ex Vivo in ART Suppressed Individuals. Submitted for Publication.
3.
BrennerS, HorneRW: A negative staining method for high resolution electron microscopy of viruses. Biochim Biophys Acta, 1959; 34:103–110.
4.
ImamichiH, DewarRL, AdelsbergerJW, RehmCA, O'DohertyU, PaxinosEE, et al.: Defective HIV-1 proviruses produce novel protein-coding RNA species in HIV infected patients on combination antiretroviral therapy. Proc Natl Acad Sci U S A, 2016; 113:8783–8788.
5.
TrubeyCM, ChertovaE, CorenLV, HilburnJM, HixsonCV, NagashimaK, et al.: Quantitation of HLA class II protein incorporated into human immunodeficiency type 1 virions purified by anti-CD45 immunoaffinity depletion of microvesicles. J Virol, 2003; 77:12699–12709.
